The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.

The recent use of interleukin 2 (IL-2) and interleukin 4 (IL-4) single cytokine modified tumour cells in rodent models has demonstrated a potential use of these cytokines to produce autologous cancer cell vaccines. Here we compare the potential therapeutic benefit of transduction with IL-2 or IL-4 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollingsworth, S. J., Darling, D., Gäken, J., Hirst, W., Patel, P., Kuiper, M., Towner, P., Humphreys, S., Farzaneh, F., Mufti, G. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074618/
https://www.ncbi.nlm.nih.gov/pubmed/8679459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074618/
https://www.ncbi.nlm.nih.gov/pubmed/8679459

Ejemplares similares